Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Microglia and prion disease.

D R Brown1

  • 1Department of Biochemistry, Cambridge University, Cambridge, CB2 1QW, United Kingdom. drb33@cam.ac.uk

Microscopy Research and Technique
|July 17, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Human papillomavirus genotypes associated with cervical cytologic abnormalities and HIV infection in Ugandan women.

Journal of medical virology·2007
Same author

Elevated manganese levels in blood and central nervous system occur before onset of clinical signs in scrapie and bovine spongiform encephalopathy.

Journal of animal science·2007
Same author

Down-regulation of MHC class I is a property common to papillomavirus E5 proteins.

Virus research·2006
Same author

Mycoplasma iguanae sp. nov., from a green iguana (Iguana iguana) with vertebral disease.

International journal of systematic and evolutionary microbiology·2006
Same author

Mycoplasma alligatoris infection promotes CD95 (FasR) expression and apoptosis of primary cardiac fibroblasts.

Clinical and diagnostic laboratory immunology·2005
Same author

Mucosal vaccination delays or prevents prion infection via an oral route.

Neuroscience·2005

Microglia activation by abnormal prion protein contributes to neurodegeneration in prion diseases. This involves reduced neuronal resistance and increased toxic substances, highlighting microglia

Area of Science:

  • Neuroscience
  • Pathology
  • Immunology

Background:

  • Prion diseases are fatal neurodegenerative disorders characterized by gliosis.
  • The exact cause of prion diseases remains unknown, despite hypotheses about protein-based infectious agents.
  • These diseases feature long incubation periods followed by rapid neurodegeneration.

Purpose of the Study:

  • To review the role of microglia in the pathological changes observed in prion diseases.
  • To elucidate the mechanisms by which microglia contribute to neuronal damage.

Main Methods:

  • Review of existing literature on prion diseases, microglia activation, and neuronal degeneration.
  • Analysis of cell culture studies involving abnormal prion protein and peptide mimics.
  • Examination of the interplay between microglia, astrocytes, and neurons.

Related Experiment Videos

Main Results:

  • Abnormal prion protein triggers microglia activation.
  • Activated microglia contribute to neurodegeneration by increasing toxic substances (e.g., reactive oxygen species) and decreasing glutamate clearance by astrocytes.
  • Microglia-derived cytokines induce astrocyte proliferation, suggesting a key role in initiating pathology.

Conclusions:

  • Microglia play a significant role in initiating and driving the neurodegenerative process in prion diseases.
  • Understanding microglia's function is crucial for developing therapeutic strategies against prion diseases.